Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric Cancer

Figure 3

The boxplot of neoantigens’ number subgrouping by age, gender, and stages. (a) The patients below 45 years (n=4) and patients above 45 years (n=28) showed no significant difference (p=0.1525). (b) The female patients (n=11) and male patients (n=21) showed no significant difference (p=0.0795). (c) The number of neoantigens differed among T1a (n=2), T2 (n=7), T4a (n=5), and T4b (n=18); the difference was significant between T1a and T2 (p=0.0202) and between T1a and T4b (p=0.0294).

(a)

(b)

(c)